Treating hypercholesterolaemia – too little, too late


Overwhelming evidence shows that hypercholesterolaemia is the pivotal causal risk factor of atherosclerotic cardiovascular disease

You will learn:

  • LDL-cholesterol lowering is the cornerstone of prevention of atherosclerotic cardiovascular disease
  • Current recommendations for LDL-cholesterol treatment targets
  • Current evidence on the use of combination therapies for achieving LDL-cholesterol targets
  • Current recommendations for the treatment of familial hypercholesterolaemia
  • The importance of tailored lipid-lowering therapy.

To access this module, please register or login: